Biomaterial-assisted macrophage cell therapy for regenerative medicine

Area of Science:

• Regenerative Medicine
• Immunology
• Biomaterials Science

Background:

• Injuries exceeding a critical threshold or disease can impair tissue repair, leading to loss of function.
• The immune system, particularly macrophages, is crucial for tissue repair, exhibiting diverse functions and phenotypes.
• Current macrophage cell therapy faces challenges with cell retention and maintaining therapeutic phenotypes post-administration.

Purpose of the Study:

• To explore challenges in macrophage cell therapy, specifically cell retention and phenotype control.
• To investigate the potential of biomaterials in overcoming these challenges for enhanced tissue regeneration.
• To discuss opportunities for next-generation regenerative medicine strategies using biomaterials.

Main Methods:

• Review of current literature on macrophage cell therapy and biomaterial applications.
• Analysis of how biomaterials can modulate macrophage behavior in situ.
• Exploration of immunomodulatory signals within cell delivery systems.

Main Results:

• Adoptively transferred macrophages often fail to maintain desired therapeutic phenotypes.
• Biomaterials offer a strategy to control macrophage phenotype and improve retention at injury sites.
• Cell delivery systems with immunomodulatory signals show promise for intractable injuries.

Conclusions:

• Biomaterials are essential for advancing macrophage cell therapy by controlling cell phenotype and retention.
• Overcoming current limitations will enable widespread clinical applications of macrophage cell therapy.
• Next-generation strategies integrating biomaterials are key to achieving tissue regeneration in complex injuries.